Pfizer Limited (PFIZER) Share Analysis
NSE · Healthcare · Pharmaceuticals
Pfizer Limited (NSE: PFIZER) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹4,002.00, market capitalisation ₹18,310 Cr, P/E 119, ROE 19.8%.
Get the AI verdict on PFIZER: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
PFIZER price and valuation
- Share price
- ₹4,002.00
- Market cap
- ₹18,310 Cr
- P/E ratio
- 119
- P/B ratio
- 13.25
- EPS
- ₹160.90
- Book value per share
- ₹302.00
- Dividend yield
- 1.87%
PFIZER profitability and growth
- ROE
- 19.8%
- ROCE
- 27.2%
- Debt to equity
- 0.02
- Revenue growth (3 yr)
- -
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- -
- Profit growth (5 yr)
- -
PFIZER 52-week range
- 52-week high
- ₹5,578.50
- 52-week low
- ₹3,955.50
- Face value
- ₹10.00
PFIZER shareholding pattern
- Promoters
- 63.92%
- FIIs
- 1.65%
- DIIs
- 17.8%
- Public
- 16.62%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.